Piramal Pharma Limited (NSE:PPLPHARMA)
India
· Delayed Price · Currency is INR 206.33
-1.75 (-0.84%)
Jun 6, 2025, 3:30 PM IST
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 274.26 billion as of June 6, 2025. Its market cap has increased by 38.67% in one year.
Market Cap
274.26B
Enterprise Value
317.62B
Revenue
91.51B
Ranking
n/a
PE Ratio
300.96
Stock Price
206.33
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 274.26B, an increase of 20.96%. That is a compound annual growth rate of 7.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 274.26B | -22.30% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,028.96B |
| Divi's Laboratories | 1,737.36B |
| Cipla | 1,214.93B |
| Apollo Hospitals Enterprise | 998.22B |
| Mankind Pharma | 970.77B |
| Zydus Lifesciences | 966.14B |
| Aurobindo Pharma | 674.37B |
| Alkem Laboratories | 581.38B |